BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35907694)

  • 1. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
    Carter M; Solsrud K; Yeddula S; Fitzmaurice MG; Singh A; Nagai S; Jafri SM
    Transplant Proc; 2022 Sep; 54(7):1737-1741. PubMed ID: 35907694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.
    Owada Y; Oshiro Y; Inagaki Y; Harada H; Fujiyama N; Kawagishi N; Yagisawa T; Usui J; Akutsu N; Itabashi Y; Saito K; Watarai Y; Ichimaru N; Imamura R; Kyakuno M; Ide K; Shibuya Y; Okabe Y; Ono M; Sasaki K; Shiose A; Yamagishi K; Ohnishi H; Nagashima S; Takahashi M; Yuzawa K; Okamoto H; Ohkohchi N
    Transplantation; 2020 Feb; 104(2):437-444. PubMed ID: 31205267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
    Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
    Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
    Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
    Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
    Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
    Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
    Ambrocio GPL; Aguado S; Carrillo J; Laporta R; Lazaro-Carrasco M; Avellon A; Aran-Toha G; Ussetti M; Aguilar M
    Transplant Proc; 2019 Mar; 51(2):376-379. PubMed ID: 30879545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.
    Del Bello A; Abravanel F; Alric L; Lavayssiere L; Lhomme S; Bellière J; Izopet J; Kamar N
    Transpl Infect Dis; 2019 Aug; 21(4):e13093. PubMed ID: 30972874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient.
    Belliere J; Abravanel F; Nogier MB; Martinez S; Cintas P; Lhomme S; Lavayssière L; Cointault O; Faguer S; Izopet J; Kamar N
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28963742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
    Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
    Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
    Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
    Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
    Aslan AT; Balaban HY
    World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and management strategies for chronic hepatitis E infection.
    Abravanel F; Lhomme S; Marion O; Péron JM; Kamar N; Izopet J
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):143-148. PubMed ID: 36625025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and treatment of hepatitis E in the liver transplantation setting: A literature review.
    Markakis GE; Papatheodoridis GV; Cholongitas E
    J Viral Hepat; 2022 Sep; 29(9):698-718. PubMed ID: 35644040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis E virus after pediatric liver transplantation.
    Getsuwan S; Pasomsub E; Yutthanakarnwikom P; Tongsook C; Butsriphum N; Tanpowpong P; Janchompoo P; Treepongkaruna S; Lertudomphonwanit C
    J Trop Pediatr; 2023 Feb; 69(2):. PubMed ID: 36811578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.